Error: Could not add to watchlist. X

Introgen Therapeutics Inc

+ Watchlist
INGNQ:US
Ticker Delisted
USD
Volume
0
Volume
0
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-0.21
Market Cap (USD)
-
Shares Outstanding (m)
44.142
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Biotech

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
Introgen Therapeutics, Inc. develops gene therapy products for the treatment of cancer. The Company's lead product candidate combines the p53 gene, a tumor suppressor gene, with a gene delivery system that it has developed and tested. Introgen is developing cancer therapies which are based on restoring normal cellular function through gene therapy.
ADDRESS
301 Congress Avenue
Suite 1850
Austin, TX 78701
United States
PHONE
1-512-708-9310